RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-9.89%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.32B
AUM Growth
+$1.32B
(+8.2%)
Cap. Flow
+$214M
Cap. Flow
% of AUM
16.24%
Top 10 Holdings %
Top 10 Hldgs %
52.92%
Holding
77
New
22
Increased
20
Reduced
12
Closed
19
Top Buys
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$74.5M |
| 2 |
Penumbra
PEN
|
$51M |
| 3 |
Incyte
INCY
|
$49.5M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
$49M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$44.3M |
Top Sells
| 1 |
Bausch Health
BHC
|
$85.4M |
| 2 |
AGN
Allergan plc
AGN
|
$41.5M |
| 3 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
$36.3M |
| 4 |
HCA Healthcare
HCA
|
$35.4M |
| 5 |
AbbVie
ABBV
|
$34.3M |
Sector Composition
| 1 | Healthcare | 77.44% |
| 2 | Communication Services | 1.09% |
| 3 | Industrials | 1% |
| 4 | Technology | 0.23% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $117M | 8.83% | 8,332,930 +2,035,407 | +32% | +$28.5M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $88.1M | 6.67% | 957,634 +198,155 | +26% | +$18.2M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $80.9M | 6.13% | 17,750,510 +4,126,890 | +30% | +$18.8M |
|
|
MDVN
4
DELISTED
MEDIVATION, INC.
MDVN
| $74.5M | 5.64% | +1,752,642 | New | +$74.5M |
|
|
5
Incyte
INCY
$16.5B
| $67.7M | 5.13% | 613,598 +448,603 | +272% | +$49.5M |
|
6
Teva Pharmaceuticals
TEVA
$21.1B
| $64.2M | 4.87% | 1,137,559 +170,200 | +18% | +$9.61M |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $53.6M | 4.06% | 1,390,173 +860,974 | +163% | +$33.2M |
|
|
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $53M | 4.01% | 1,322,592 +712,421 | +117% | +$28.5M |
|
|
9
Penumbra
PEN
$10.6B
| $51M | 3.86% | +1,562,587 | New | +$51M |
|
|
RAD
10
DELISTED
Rite Aid Corporation
RAD
| $49M | 3.71% | +8,071,405 | New | +$49M |
|
|
SAGE
11
DELISTED
Sage Therapeutics
SAGE
| $48.4M | 3.66% | 1,142,864 +852,514 | +294% | +$36.1M |
|
|
WCG
12
DELISTED
Wellcare Health Plans, Inc.
WCG
| $44.3M | 3.36% | +514,273 | New | +$44.3M |
|
|
CMRX
13
DELISTED
Chimerix, Inc.
CMRX
| $40.8M | 3.09% | 1,067,978 +368,553 | +53% | +$14.1M |
|
14
Centene
CNC
$14.3B
| $40.5M | 3.07% | +747,460 | New | +$40.5M |
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $38.8M | 2.94% | 368,775 +161,031 | +78% | +$17M |
|
|
ZSPH
16
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $33.8M | 2.56% | 514,107 +211,119 | +70% | +$13.9M |
|
17
Atara Biotherapeutics
ATRA
$84.6M
| $33M | 2.5% | 1,049,782 +677,140 | +182% | +$21.3M |
|
|
PTLA
18
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $32.8M | 2.49% | 769,641 +616,941 | +404% | +$26.3M |
|
|
NDRM
19
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $30.2M | 2.29% | +1,462,699 | New | +$30.2M |
|
|
NSTG
20
DELISTED
NanoString Technologies, Inc.
NSTG
| $22.2M | 1.68% | 1,385,641 -74,101 | -5% | -$1.19M |
|
21
Celldex Therapeutics
CLDX
$1.47B
| $20.6M | 1.56% | 1,954,019 +1,921,254 | +5,864% | +$20.2M |
|
|
DBVT
22
DBV Technologies
DBVT
$264M
| $19M | 1.44% | +532,818 | New | +$19M |
|
23
Dynavax Technologies
DVAX
$1.19B
| $17.8M | 1.35% | +724,348 | New | +$17.8M |
|
24
Insmed
INSM
$28.8B
| $17.6M | 1.33% | 947,966 +80,620 | +9% | +$1.5M |
|
|
MODN
25
DELISTED
MODEL N, INC.
MODN
| $14.4M | 1.09% | 1,443,278 | – | – |
|